ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Reckitt Benckiser Group PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action – RBGLY

Group 1 - The Rosen Law Firm is reminding purchasers of American Depositary Shares (ADSs) of Reckitt Benckiser Group PLC about the lead plaintiff deadline of August 4, 2025, for a class action lawsuit [1] - Investors who purchased Reckitt ADSs may be entitled to compensation through a contingency fee arrangement, meaning no out-of-pocket fees or costs [2] - A class action lawsuit has already been filed, and interested parties can join by contacting the Rosen Law Firm [3][6] Group 2 - The lawsuit alleges that during the class period, Reckitt failed to warn investors that preterm infants were at increased risk of developing necrotizing enterocolitis (NEC) from consuming its Enfamil formula, which misled investors about the company's business prospects [5]